Thomas J. Errico Buys 6,000 Shares of electroCore, Inc. (NASDAQ:ECOR) Stock

electroCore, Inc. (NASDAQ:ECOR) Director Thomas J. Errico bought 6,000 shares of electroCore stock in a transaction on Monday, March 17th. The stock was acquired at an average price of $8.10 per share, for a total transaction of $48,600.00. Following the purchase, the director now owns 256,401 shares of the company’s stock, valued at approximately $2,076,848.10. This trade represents a 2.40 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

electroCore Price Performance

ECOR opened at $8.38 on Wednesday. The business’s 50-day moving average is $15.47 and its two-hundred day moving average is $12.38. electroCore, Inc. has a 1 year low of $5.32 and a 1 year high of $19.49. The firm has a market capitalization of $55.78 million, a PE ratio of -4.58 and a beta of 0.24.

Institutional Investors Weigh In On electroCore

Large investors have recently modified their holdings of the business. Geode Capital Management LLC grew its stake in shares of electroCore by 10.3% during the third quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after acquiring an additional 5,951 shares during the last quarter. HighTower Advisors LLC purchased a new stake in shares of electroCore during the third quarter worth about $255,000. Jane Street Group LLC purchased a new stake in shares of electroCore during the fourth quarter worth about $278,000. JPMorgan Chase & Co. grew its stake in shares of electroCore by 31,250.0% during the fourth quarter. JPMorgan Chase & Co. now owns 3,762 shares of the company’s stock worth $61,000 after acquiring an additional 3,750 shares during the last quarter. Finally, Marshall Wace LLP purchased a new stake in shares of electroCore during the fourth quarter worth about $438,000. Hedge funds and other institutional investors own 26.74% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ECOR. LADENBURG THALM/SH SH decreased their price objective on electroCore from $28.00 to $26.00 and set a “buy” rating for the company in a report on Thursday, March 13th. HC Wainwright reiterated a “buy” rating and issued a $25.00 target price on shares of electroCore in a research note on Thursday, March 13th.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.